Brind.

Iovance Biotherapeutics drafted Jefferies Financial Group to be its sales agency.

1 report, 1 independent Updated Aug 26

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Iovance Biotherapeutics Jefferies Financial Group

Keep exploring

The entities involved

Iovance Biotherapeutics
American biopharmaceutical startup

Nothing else this week.
Jefferies Financial Group
American financial services company
- Apple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Mon 17:22
- Jefferies reaffirmed Amazon's stock buy rating on June 18, 2026.Mon 12:11

Related events

Iovance Biotherapeutics received FDA approval for its therapy, and the company is listed on Nasdaq.Jun 20

Coverage

Newest first; wire copies grouped

Aug 26Motley FoolWhy Iovance Biotherapeutics Stock Got Mashed on Monday The biotech is floating an at-the-market, secondary stock issue. It will use the funds to advance its top commercialized drug and further develo